Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
16 Feb, 23
Key session presented at the International Congress of Infectious Diseases (ISID), 17th-20th Nov. 2022, Malaysia.
A single-center real-life study evaluated the clinical and laboratory parameters of patients with severe allergic asthma classified as super-responder or non super-responder to omalizumab. The study identified high blood eosinophil levels, chronic rhinosinusitis with nasal polyps, and low pre-treatment lung capacity as predictors of omalizumab treatment response.
A new study reported that elevated urine albumin-to-creatinine ratio (uACR) is an independent risk factor for new-onset heart failure (HF) in patients with T2D. The risk of HF increases by 2.21fold when uACR is mildly elevated (3–30 mg/mmol) and when uACR ≥30 mg/mmol, the risk of HF increases by 6.02 fold. The findings may serve as reference for screening and assessing high-risk HF patients in T2D patients.
- The treat-to-target LDL-C strategy of 50 to 70 mg/dL as the goal was noninferior to the high-intensity statin strategy for major clinical outcomes
- In treat-to-target strategy group, the rate of the 3-year composite of all-cause death, MI, stroke, or any coronary revascularization was 8.1% compared with 8.7% in the high-intensity statin therapy group
- The overall prevalence of CVDs was 5.2% (women: 4.6%; men: 5.9%), CHD/heart attacks was 2.8% and stroke was 1.6% in a longitudinal ageing study in India, 2017-2019
- Patients with hypertension and DM showed higher prevalence of CVDs compared to patients without hypertension and DM
- Hypertension, hypercholesterolemia, diabetes, obesity, physical inactivity, and smoking in men were significantly associated with C...
Featured

1 Mar, 23

23 Feb, 23

23 Feb, 23